April 07, 2026

Neoadjuvant/Adjuvant Doublet Significantly Improved Survival in Patients With Muscle-Invasive Bladder Cancer

The combination of the NECTIN4-directed antibody drug conjugate enfortumab vedotin-ejfv and the immunotherapy drug pembrolizumab is the established first-line standard-of-care treatment for patients w...

The ASCO Post

April 06, 2026

Jose “Pepe” Alvarez Jr., M.D., Memorial Lecture on Vascular Disease: Modern Approaches to Managing Carotid Disease

Please join us to hear James F. Meschia, M.D., FAHA, Professor of Neurology and Chair Emeritus at the Mayo Clinic, present Modern Approaches to Managing Carotid Disease.

Baptist Health South Florida

April 06, 2026

Centre for Sight Marks 30 Years with Conference 

Event will examine how the technologies, skills, and business models have evolved and are set to face the future

The Ophthalmologist

April 03, 2026

Study Finds GLP-1RAs Were Associated With a Reduced Risk of Developing Colorectal Cancer vs Aspirin

Excluding skin cancers, colorectal cancer is the third most common cancer diagnosed in both men and women in the United States. According to the American Cancer Society, in 2025, about 154,270 individ...

The ASCO Post

April 03, 2026

Acoramidis Linked to Lower Mortality Through 54 Months

Early treatment was associated with sustained reductions in mortality and cardiovascular hospitalization in transthyretin amyloid cardiomyopathy

Conexiant

April 01, 2026

Evolocumab Reduced CV Events in Diabetes

Subgroup analysis of the VESALIUS-CV trial supports earlier intensive lipid lowering

Conexiant

April 01, 2026

Tirzepatide Linked to Lower Cardiorenal Events

Researchers evaluate expanded six-component outcome in high-risk patients with diabetes

Conexiant

March 31, 2026

Sudden Death Trajectories in HFpEF, HFmrEF

Clinical changes before death overlap across outcomes

Conexiant

March 30, 2026

What to Expect at HTC-19

Leuven hosts HTC-19 this May, bringing scientists and industry together to explore the latest advances in hyphenated separations, AI-driven analysis, and next-generation analytical workflows

The Analytical Scientist

March 30, 2026

Pregnancy-Linked SCAD More Severe

Data presented at the American College of Cardiology 75th Annual Scientific Session linked pregnancy-associated SCAD to more severe presentation and higher in-hospital major adverse cardiovascular events.

Conexiant